Global Imipenem Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Imipenem Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Imipenem is a broad spectrum carbapenem antibiotic which is used for severe bacterial infections.
Imipenem report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Imipenem market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Injection and Other are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Imipenem industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Imipenem key manufacturers include Savior Lifetec, Sun Pharmaceutical Industries, HISUN Pharmaceutical, Haibin Pharmaceutical, Jiangxi Fushine Pharmaceutical and HISOAR, etc. Savior Lifetec, Sun Pharmaceutical Industries, HISUN Pharmaceutical are top 3 players and held % sales share in total in 2022.
Imipenem can be divided into Sterile Type and Non-sterile Type, etc. Sterile Type is the mainstream product in the market, accounting for % sales share globally in 2022.
Imipenem is widely used in various fields, such as Injection and Other, etc. Injection provides greatest supports to the Imipenem industry development. In 2022, global % sales of Imipenem went into Injection filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Imipenem market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Savior Lifetec
Sun Pharmaceutical Industries
HISUN Pharmaceutical
Haibin Pharmaceutical
Jiangxi Fushine Pharmaceutical
HISOAR
Segment by Type
Sterile Type
Non-sterile Type
Injection
Other
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Imipenem market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Imipenem, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Imipenem industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Imipenem in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Imipenem introduction, etc. Imipenem Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Imipenem market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Imipenem report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Imipenem market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Injection and Other are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Imipenem industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Imipenem key manufacturers include Savior Lifetec, Sun Pharmaceutical Industries, HISUN Pharmaceutical, Haibin Pharmaceutical, Jiangxi Fushine Pharmaceutical and HISOAR, etc. Savior Lifetec, Sun Pharmaceutical Industries, HISUN Pharmaceutical are top 3 players and held % sales share in total in 2022.
Imipenem can be divided into Sterile Type and Non-sterile Type, etc. Sterile Type is the mainstream product in the market, accounting for % sales share globally in 2022.
Imipenem is widely used in various fields, such as Injection and Other, etc. Injection provides greatest supports to the Imipenem industry development. In 2022, global % sales of Imipenem went into Injection filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Imipenem market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Savior Lifetec
Sun Pharmaceutical Industries
HISUN Pharmaceutical
Haibin Pharmaceutical
Jiangxi Fushine Pharmaceutical
HISOAR
Segment by Type
Sterile Type
Non-sterile Type
Segment by Application
Injection
Other
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Imipenem market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Imipenem, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Imipenem industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Imipenem in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Imipenem introduction, etc. Imipenem Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Imipenem market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices